This grant is for continuing support of the Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium. The Consortium focuses on SCLC prevention, diagnosis, treatment, and mechanisms of treatment resistance. The CC’s multifaceted role includes administrative coordination, establishing and maintaining databases for omics and other pertinent data, and securing centralized tissue banking with a virtual biospecimen database for Consortium members. It will also provide centralized biostatistics, bioinformatics, and data analysis support, establish SCLC in vivo and in vitro model repositories, and manage meeting and communication coordination. Furthermore, the CC will be responsible for creating and maintaining the Consortium’s website, ensuring comprehensive support for its research goals.
Opportunity ID: 335966
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-346 |
| Funding Opportunity Title: | Limited Competition: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 29, 2021 |
| Last Updated Date: | Sep 29, 2021 |
| Original Closing Date for Applications: | Nov 17, 2021 |
| Current Closing Date for Applications: | Nov 17, 2021 |
| Archive Date: | Dec 23, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $940,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. See full Funding Opportunity Announcement for Eligibility details. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this limited competition Funding Opportunity Announcement (FOA) is to continue support for the Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (Consortium) that will be focused on prevention, diagnosis, treatment, and mechanisms of treatment resistance in SCLC. The CC will support the administrative coordination of the SCLC Consortium, create and support database(s) for -omics or other data pertinent to the Consortium, secure centralized tissue banking for specimens submitted by the members of the Consortium and a virtual biospecimen database that would include all tissue resources of the Consortium, provide centralized biostatistics, bioinformatics and data analysis support, establish SCLC in vivo and in vitro model repositories and distribution units, support meeting and communications coordination among members of Consortium, and form and maintain a Consortium website. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-346.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00269141 | Oct 17, 2021 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00269584 | Oct 27, 2021 | Nov 17, 2021 | View |
Package 1
Mandatory forms
335966 RR_SF424_2_0-2.0.pdf
335966 PHS398_CoverPageSupplement_5_0-5.0.pdf
335966 RR_OtherProjectInfo_1_4-1.4.pdf
335966 PerformanceSite_2_0-2.0.pdf
335966 RR_KeyPersonExpanded_2_0-2.0.pdf
335966 RR_Budget_1_4-1.4.pdf
335966 PHS398_ResearchPlan_4_0-4.0.pdf
335966 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
335966 RR_SubawardBudget30_1_4-1.4.pdf
335966 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
335966 RR_SF424_5_0-5.0.pdf
335966 PHS398_CoverPageSupplement_5_0-5.0.pdf
335966 RR_OtherProjectInfo_1_4-1.4.pdf
335966 PerformanceSite_4_0-4.0.pdf
335966 RR_KeyPersonExpanded_4_0-4.0.pdf
335966 RR_Budget_3_0-3.0.pdf
335966 PHS398_ResearchPlan_4_0-4.0.pdf
335966 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
335966 RR_SubawardBudget30_3_0-3.0.pdf
335966 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
